UROsphere and Vectalys selected by the SISMIP for their research program «Novel gene targets discovery for prostatic pathologies ».

Vectalys and UROsphere (a company specialized in urologic deseases) are pleased to announce the selection of the research programme « Discovery of new targets for prostatic pathologies ». This program has been retained through an innovative project call organized by SISMIP (Health Industries Network in the Midi-Pyrenees Region) and DRIRE Midi-Pyrenees (Regional Board for Industries, Research and Environment).
Both companies will work together on the programme for 1 year.

The 3SI program for Innovation in the Health Sector is a call for innovative projects reserved to SMEs located in Midi-Pyrenees Region. This program is also supported by the Regional Board of OSEO (France's national agency for industrial innovation), the Regional Board for Research and Technology (DRRT), the Cancer-Bio-Health cluster and Midi Pyrénées Innovation (MPI).